The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
2SEVENTY BIO INC | COMMON STOCK | 901384107 | 14,258,078 | 1,408,901 | SH | SOLE | 1,408,901 | 0 | 0 | ||
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 35,258,000 | 3,400,000 | SH | SOLE | 3,400,000 | 0 | 0 | ||
ANNEXON INC | COM | 03589W102 | 20,070,780 | 5,701,926 | SH | SOLE | 5,701,926 | 0 | 0 | ||
ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | 28,590,000 | 3,000,000 | SH | SOLE | 3,000,000 | 0 | 0 | ||
ATEA PHARMACEUTICALS INC | COM | 04683R106 | 9,296,286 | 2,485,638 | SH | SOLE | 2,485,638 | 0 | 0 | ||
C4 THERAPEUTICS INC | COM STK | 12529R107 | 4,516,078 | 1,642,210 | SH | SOLE | 1,642,210 | 0 | 0 | ||
CABALETTA BIO INC | COM | 12674W109 | 25,820,000 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
CARA THERAPEUTICS INC | COM | 140755109 | 2,645,761 | 934,898 | SH | SOLE | 934,898 | 0 | 0 | ||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 41,546,155 | 2,305,558 | SH | SOLE | 2,305,558 | 0 | 0 | ||
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 27,375,000 | 2,500,000 | SH | SOLE | 2,500,000 | 0 | 0 | ||
DISC MEDICINE INC | COM | 254604101 | 59,165,131 | 1,332,548 | SH | SOLE | 1,332,548 | 0 | 0 | ||
DYNAVAX TECHNOLOGIES CORP | COM NEW | 268158201 | 31,201,800 | 2,415,000 | SH | SOLE | 2,415,000 | 0 | 0 | ||
EQRX INC | COM | 26886C107 | 18,606,646 | 10,003,573 | SH | SOLE | 10,003,573 | 0 | 0 | ||
INVIVYD INC | COM | 00534A102 | 2,034,067 | 1,937,207 | SH | SOLE | 1,937,207 | 0 | 0 | ||
MARINUS PHARMACEUTICALS INC | COM NEW | 56854Q200 | 15,541,290 | 1,431,058 | SH | SOLE | 1,431,058 | 0 | 0 | ||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 28,503,484 | 8,663,673 | SH | SOLE | 8,663,673 | 0 | 0 | ||
NATERA INC | COM | 632307104 | 34,071,586 | 700,197 | SH | SOLE | 700,197 | 0 | 0 | ||
NAUTILUS BIOTECHNOLOGY INC | COM | 63909J108 | 7,740,000 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | N62509109 | 124,534,826 | 10,473,913 | SH | SOLE | 10,473,913 | 0 | 0 | ||
NEWAMSTERDAM PHARMA COMPANY | *W EXP 11/22/202 | N62509117 | 209,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
NURIX THERAPEUTICS INC | COM | 67080M103 | 18,210,601 | 1,822,883 | SH | SOLE | 1,822,883 | 0 | 0 | ||
NUVALENT INC | COM | 670703107 | 150,853,349 | 3,577,267 | SH | SOLE | 3,577,267 | 0 | 0 | ||
PHARVARIS N V | COM | N69605108 | 73,713,390 | 4,868,784 | SH | SOLE | 4,868,784 | 0 | 0 | ||
RAPID MICRO BIOSYSTEMS INC | CLASS A COM | 75340L104 | 8,434,560 | 8,434,560 | SH | SOLE | 8,434,560 | 0 | 0 | ||
SAVARA INC | COM | 805111101 | 37,134,201 | 11,622,598 | SH | SOLE | 11,622,598 | 0 | 0 | ||
SOLID BIOSCIENCES INC | COM NEW | 83422E204 | 16,403,411 | 3,130,422 | SH | SOLE | 3,130,422 | 0 | 0 | ||
SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 80,791,870 | 3,081,307 | SH | SOLE | 3,081,307 | 0 | 0 | ||
SYROS PHARMACEUTICALS INC | COM NEW | 87184Q206 | 6,692,786 | 2,124,694 | SH | SOLE | 2,124,694 | 0 | 0 | ||
TANGO THERAPEUTICS INC | COM | 87583X109 | 6,380,343 | 1,921,790 | SH | SOLE | 1,921,790 | 0 | 0 | ||
THIRD HARMONIC BIO INC | COM | 88427A107 | 3,081,435 | 640,631 | SH | SOLE | 640,631 | 0 | 0 | ||
X4 PHARMACEUTICALS INC | COM | 98420X103 | 30,963,541 | 15,960,588 | SH | SOLE | 15,960,588 | 0 | 0 | ||
XILIO THERAPEUTICS INC | COM | 98422T100 | 7,350,182 | 2,805,413 | SH | SOLE | 2,805,413 | 0 | 0 |